Public release of the FinnGen data freeze 2 results and summary statistics

We are excited to announce that the FinnGen data freeze 2 results and summary statistics are now publicly available!

According to the FinnGen consortium agreement, FinnGen results are subjected to one year embargo and, after that, can be made available to the larger scientific community. FinnGen Steering Committee has decided to release the results and the summary statistics for FinnGen data freeze 2 from November 2018. This data freeze consists of 96,499 individuals, more than 16 M variants and 1,122 disease endpoints.

The results can be browsed online using the FinnGen web browser. Related summary statistics can be also downloaded free of charge. Please follow the instructions given on this page.

FinnGen in brief

FinnGen is a large public-private partnership aiming to collect and analyse genome and health data from 500,000 Finnish biobank participants. FinnGen aims on one hand to provide novel medically and therapeutically relevant insights but also construct a world-class resource that can be applied for future studies.

FinnGen is one of the very first personalized medicine projects at this scale and the public-private collaborative nature of the project is exceptional compared to many ongoing studies. FinnGen brings together Finnish universities, hospitals and hospital districts, THL, Blood Service, biobanks, FINBB and international pharmaceutical companies and hundreds of thousands of Finns. Because collaboration is the key to achieving breakthroughs in disease prevention, diagnosis, and treatment, we welcome everyone on this journey into our shared heritage.